{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-101007","form_type":"8-K","ticker":"SPIR","cik":"0001816017","company_name":"Spire Global, Inc.","filed_at":"2024-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.632036+00:00","generated_at":"2026-05-31T07:26:56.722529+00:00","sec_items":["2.02","4.02","3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Spire Global restates financials for FY2022-2023 and certain quarters; NYSE non-compliance notice","bullets":["Audit committee concludes 2022, 2023 annual and 2022-2024 quarterly financials can no longer be relied upon due to revenue recognition errors.","Estimated annual revenue impact of $10-15M from incorrect pre-space mission activity revenue; no cash flow impact expected.","NYSE notified company of non-compliance for late Q2 2024 10-Q; deadline to file is February 19, 2025.","Company plans to file amended periodic reports and Q2 2024 10-Q within the six-month cure period.","Management evaluating possible material weaknesses in internal controls; will be disclosed in amended filings."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-101007","json":"https://secwatch.observer/filing/0000950170-24-101007.json","markdown":"https://secwatch.observer/filing/0000950170-24-101007.md","text":"https://secwatch.observer/filing/0000950170-24-101007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816017/000095017024101007/0000950170-24-101007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816017/000095017024101007/spir-20240821.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:26:56.722529+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001213900-26-062844","ticker":"ADTX","company_name":"Aditxt, Inc.","filed_at":"2026-05-29T20:21:24+00:00","headline":"Aditxt receives Nasdaq deficiency for negative equity; delisting hearing set for June 11","event_type":"other_material","sec_items":["3.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 3.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062844","json":"https://secwatch.observer/filing/0001213900-26-062844.json","markdown":"https://secwatch.observer/filing/0001213900-26-062844.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/0001213900-26-062844-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/ea0292786-8k_aditxt.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-068279","ticker":null,"company_name":"Pacific Coast Oil Trust","filed_at":"2026-05-29T20:16:16+00:00","headline":"Pacific Coast Oil Trust: no May distribution, $13.7M owed to PCEC, dissolution pending litigation","event_type":"other_material","sec_items":["2.02","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 2.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068279","json":"https://secwatch.observer/filing/0001104659-26-068279.json","markdown":"https://secwatch.observer/filing/0001104659-26-068279.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1538822/000110465926068279/0001104659-26-068279-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1538822/000110465926068279/tm2616038d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-066974","ticker":"LIMN","company_name":"Liminatus Pharma, Inc.","filed_at":"2026-05-27T20:30:41+00:00","headline":"Liminatus Pharma receives Nasdaq delisting notice; appeals filed","event_type":"other_material","sec_items":["3.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 3.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-066974","json":"https://secwatch.observer/filing/0001104659-26-066974.json","markdown":"https://secwatch.observer/filing/0001104659-26-066974.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/0001104659-26-066974-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/tm2615785d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001539497-26-001594","ticker":"RITE","company_name":"MINERALRITE Corp","filed_at":"2026-05-27T20:02:13+00:00","headline":"MineralRite restates financials, cuts asset carrying value from $432M to $246M","event_type":"other_material","sec_items":["4.02","7.01","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 4.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001539497-26-001594","json":"https://secwatch.observer/filing/0001539497-26-001594.json","markdown":"https://secwatch.observer/filing/0001539497-26-001594.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1096296/000153949726001594/0001539497-26-001594-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1096296/000153949726001594/n4863_x26-8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-240509","ticker":"MNRO","company_name":"MONRO, INC.","filed_at":"2026-05-27T11:44:18+00:00","headline":"Monro initiates strategic alternatives review; Q4 sales down 7.2%, operating loss narrows","event_type":"other_material","sec_items":["2.02","7.01","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 2.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-240509","json":"https://secwatch.observer/filing/0001193125-26-240509.json","markdown":"https://secwatch.observer/filing/0001193125-26-240509.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/876427/000119312526240509/0001193125-26-240509-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/876427/000119312526240509/d128639d8k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026529","ticker":"HCWB","company_name":"HCW Biologics Inc.","filed_at":"2026-06-01T11:30:18+00:00","headline":"Nasdaq panel grants HCW Biologics extension to July 29, 2026 to regain $1 bid price compliance","event_type":"other_material","sec_items":["3.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 3.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026529","json":"https://secwatch.observer/filing/0001493152-26-026529.json","markdown":"https://secwatch.observer/filing/0001493152-26-026529.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/0001493152-26-026529-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-245264","ticker":"SF","company_name":"STIFEL FINANCIAL CORP","filed_at":"2026-05-28T20:15:22+00:00","headline":"Stifel's April 2026 operating data: client assets up 17% YoY to $568.9B","event_type":"other_material","sec_items":["7.01","2.02","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 2.02","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-245264","json":"https://secwatch.observer/filing/0001193125-26-245264.json","markdown":"https://secwatch.observer/filing/0001193125-26-245264.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/720672/000119312526245264/0001193125-26-245264-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/720672/000119312526245264/d130492d8k.htm"},"side_by_side_evidence":null},{"accession":"0001477932-26-003440","ticker":"GWLL","company_name":"GOLDENWELL BIOTECH, INC.","filed_at":"2026-05-27T00:17:04+00:00","headline":"Goldenwell Biotech to restate three quarterly reports over $9,840 legal fee timing errors","event_type":"other_material","sec_items":["4.02","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 4.02","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-003440","json":"https://secwatch.observer/filing/0001477932-26-003440.json","markdown":"https://secwatch.observer/filing/0001477932-26-003440.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800373/000147793226003440/0001477932-26-003440-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800373/000147793226003440/gdwl_8k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}